Pharmacology of quinpirole-stimulated [35S]GTPγS binding: Discrepancy with receptor binding profile

European Journal of Pharmacology

Volumn 392, Issue 3, 2000, Pages 125-128

  Gilliland, Sarah L ^a   Alper, Richard H ^a   Levant, Beth ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

agonist stimulated; Dopamine D2 like receptor; Monoamine oxidase inhibitor; Quinpirole; Rat; Striatum; 35S GTP S binding

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLORGYLINE; CLOZAPINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HALOPERIDOL; N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE; QUINPIROLE; SELEGILINE; SPIPERONE;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CORPUS STRIATUM; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BINDING, COMPETITIVE; CLORGYLINE; CLOZAPINE; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HALOPERIDOL; MALE; MEMBRANES; MONOAMINE OXIDASE INHIBITORS; QUINPIROLE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SELEGILINE; SPIPERONE; SULFUR RADIOISOTOPES; THIAZOLES;

EID: 0034737564     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00124-2     Document Type: Article

References (14)

1. Clark D., White F.J. Review: D1 dopamine receptor-the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional significance. Synapse. 1:1987;347-388.
2. Culver K.E., Rosenfeld J.M., Szechtman H. A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats. Psychopharmacology. 2000;. (in press).
3. Culver K.E., Szechtman H. Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole. Eur. J. Pharmacol. 339:1997;109-111.
4. 35S]GTPγS binding. Life Sci. 65:1999;1633-1645.
5. Lachowicz J.E., Sibley D.R. Molecular characteristics of mammalian dopamine receptors. Pharmacol. Toxicol. 81:1997;105-113.
6. Lahti R.A., Figur L.M., Piercey M.F., Ruppel P.L., Evans D.L. Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding-coupled receptor: utilization of receptor state binding affinities. Mol. Pharmacol. 42:1992;432-438.
7. 3H]quinpirole binding by a monoamine oxidase inhibitor in subcellular fractions of rat striatum. Life Sci. 63:1998;1643-1651.
8. 2-like dopamine receptors in rat brain. J. Pharmacol. Exp. Ther. 262:1992;929-935.
9. 3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study. J. Pharmacol. Exp. Ther. 264:1993;991-1001.
10. 3H]quinpirole binding in rat striatal membranes. Eur. J. Pharmacol. 246:1993;171-178.
11. 3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site. J. Pharmacol. Exp. Ther. 278:1996;145-153.
12. 35S]GTP(S) binding in rat striatal membranes. Biochem. Pharmacol. 57:1999;155-162.
13. Seeman P. Receptor tables. Drug Dissociation Constants for Neuroreceptors and Transporters. Vol. 2:1993;SZ Research, Toronto.
14. 3H]quinpirole. Eur. J. Pharmacol. 203:1991;105-109.